Wacker Chemie AG Elevator Pitch | A Leader in Specialty Chemicals and Sustainability

Introduction to Wacker Chemie:Joerg Hoffmann introduces Wacker Chemie, a global leader in speciality chemical manufacturing. With over 16,000 employees, the company achieved an impressive €6.4 billion in sales and €824 million EBITDA in 2023, a testament to its exceptional performance. The company operates through four distinct business segments, each vitally involved in delivering innovative solutions to diverse industries worldwide. These segments are Silicones, Polymers, Polysilicon, and solutions.Business Segments at a GlanceSiliconesWacker'sThe largest segment, Silicones, represents a cornerstone of Wacker’s business. Silicones are versatile materials in countless applications, from construction and healthcare to renewable energy and automotive. With 85% of sales driven by speciality silicone products, the segment demonstrates WaWacker'socus on high-margin, customised solutions. The presentation also highlights the integration of silicones with polysilicon production, maximising resource efficiency.PolymersThe Polymers segment specialises in adhesives, paints, and coatings, playing a key role in sustainable construction. Through innovations like dispersible polymer powders and vinyl acetate ethylene-based adhesives, Wacker delivers solutions that enhance energy efficiency and reduce carbon footprints. Applications include construction materials, food packaging, and textiles, with significant growth driven by the global trend toward urbanisation and green building standards.PolysiliconworldwideWacker is the global leader in polysilicon manufacturing for semiconductor and solar applications. Nearly half of all computer microchips globally contain Wacker polysilicon, which is pivotal in enabling cutting-edge technologies such as artificial intelligence, connectivity, and renewable energy solutions. The solar segment also benefits from WaWacker'superior quality and cost efficiency, which positions the company as a leader in sustainable energy transformation.BiosolutionsThe Biosolutions division is a fast-growing business focusing on biotechnology and advanced medicine. Through mRNA and pDNA production innovations, Wacker addresses high-growth markets in biopharmaceuticals and nutraceuticals. Its expertise in microbial fermentation supports next-generation pharmaceuticals, emphasising sustainability and scalability in drug manufacturing processes.Strategic Focus and Market LeadershipWacker Chemie prides itself on being a market leader in all its segments, ranking as #1 or #2 globally. The presentation underscores the company’s unique position in leveraging its integrated value chain and advanced technology to provide tailored solutions across multiple industries, including construction, healthcare, electronics, and renewable energy. WaWacker'sommitment to innovation is evident in its continuous development of new products and solutions.▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/Company Presentation: https://seat11a.com/investor-relations-company-presentation/Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ESG Presentation: https://seat11a.com/investor-relations-esg/T&CThis publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.